Trailing-twelve-month (TTM) revenue is $1.58 Million with a year-over-year growth of (76.20%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $132,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $718,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-18 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $733,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $1,583,000 |
Current P/S: $442,336,800 market capitalization ÷ $1,583,000 TTM revenue = 279.43x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $733000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:52:16.201Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| License | $12M | $2M | N/A |
| Related Party | $196M | N/A | N/A |
| Reportable Segment | N/A | N/A | $7M |
$1.58M
$1.58 Million
(76.20%)
vs. $6.65M a year ago (TTM)
(62.76%)
5 Year compound annual growth rate
1 Year
(76.20%)
3 Year
+99.80%
5 Year
(62.76%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.25M | +$6.69M | +1181.27% |
| 2024 | $566,000 | +$174,000 | +44.39% |
| 2023 | $392,000 | ($1.11M) | (73.91%) |
| 2022 | $1.50M | ($206.88M) | (99.28%) |
| 2021 | $208.38M | +$195.77M | +1551.57% |
TTM Growth
(76.20%)
3-Year CAGR
+99.80%
5-Year CAGR
(62.76%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 15 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:52:16.201Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
